Skip to main content

Table 4 RDW in study groups, gender and age-groups

From: Prognostic Potential of RDW in Discriminating Hemoglobinopathies among Patients reporting to Aga Khan Hospital, Kisumu

RDW-CV (%)

Medians (interquartile ranges)

 

Control (n = 241)

p

Cases (n = 247)

p

Male (n = 214)

 ≤ 5 years

16.75 (4.7)

0.042

21.75 (6.54)

0.145

6–12 years

15.1(1.6)

20.25 (7.96)

 ≤ 5 years

16.75 (4.7)

 < 0.0001

21.75 (6.54)

 ≥ 13 years

13.70(1.8)

20.1 (8.36)

6-12 years

15.1 (1.6)

0.137

20.25 (7.96)

 ≥ 13 years

13.7 (1.8)

20.1 (8.36)

Females (n = 274)

 ≤ 5 year

15.55 (3.76)

0.017

21.0 (7.04)

0.732

6-12yeas

13.8 (1.81)

19.65 (8.37)

 ≤ 5 years

15.55 (3.76)

 < 0.0001

21.0 (7.04)

 < 0.0001

 ≥ 13 years

13.75 (2.22)

14.75 (7.34)

6-12 years

13.8 (1.81)

0.860

19.65 (8.37)

0.024

 ≥ 13 years

13.75 (2.22)

14.75 (7.34)